De ontwikkeling van een ALS therapie gericht op Ataxine-2. The development of an ALS therapy focused on Ataxin-2

Project Number
EUJPND-Hersenstichting-Multiple PI-1643
Agency/Funding Organization
Hersenstichting
Funding Year
2016
Research Categorization
Researcher and Organization
Principal Investigator
Principal Investigator First Name
Multiple PI
Principal Investigator Last Name
Multiple PI
Awardee Organization
Contact PI Country
Project Detail
FY Overall Cost
$14,033
Funding Organization
Agency/Funding Organization
Funding Organization Country